Shahar Keinan, CEO of POLARIS Quantum Biotech, Has Agreed to Speak May 20 at 2:40 on ‘Quantum Computing and the Design of New Drugs and Materials’ at Inside Quantum Technology Fall 2021
(IQT.Event.Fall) Shahar Keinan, CEO of POLARIS Quantum Biotech, has agreed to speak May 20 at 2:40 pm – Panel 3: ‘Quantum Computing and the Design of New Drugs and Materials’ at Inside Quantum Technology Fall 2021.
Dr. Shahar Keinan is the CEO & co-founder of POLARIS Quantum Biotech. She has over 20 years of extensive experience in the field of computational and theoretical chemistry and published over 50 peer-reviewed manuscripts in the fields of in-silico drug design and discovery, as well as molecular materials design and computational methods development. Shahar has received a Ph.D. in theoretical chemistry from The Hebrew University of Jerusalem, after which she moved to Northwestern University and Duke University for a post-doc positions. Previously she was CSO of Cloud Pharmaceuticals and has been instrumental in the development of the Quantum Molecular Design process since its inception at Duke University, and has pioneered the use of Inverse Design algorithms to optimize electro-optical materials and small molecule drugs.
“(IQT)…has quickly become the quantum industry’s leading conference.” —ZDNET
The Inside Quantum Technology Conference focuses on the Business of Quantum Computing, Quantum Networking, Quantum Sensors, and Quantum Cryptography. This will be the fourth such event and is the foremost gathering of business leaders, product developers, marketing strategists and investors anywhere in the world focused on quantum technology. We are anticipating that over 1,000 people will be attending this event from all over the world and from every area of quantum technology.